Your browser doesn't support javascript.
loading
Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study.
Rigal, Adrien; Colle, Romain; Asmar, Khalil El; Trabado, Séverine; Loeb, Emanuel; Martin, Séverine; Choucha, Walid; Gressier, Florence; Costemale-Lacoste, Jean-Francois; de Larminat, Delphine; Deflesselle, Eric; Fève, Bruno; Chanson, Philippe; Becquemont, Laurent; Verstuyft, Céline; Corruble, Emmanuelle.
Afiliação
  • Rigal A; Faculté de Médecine Paris-Sud, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • Colle R; INSERM UMR-1178, CESP, Le Kremlin-Bicêtre, France.
  • Asmar KE; Service Hospitalo-Universitaire de Psychiatrie et Addictologie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Trabado S; Faculté de Médecine Paris-Sud, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • Loeb E; INSERM UMR-1178, CESP, Le Kremlin-Bicêtre, France.
  • Martin S; Service Hospitalo-Universitaire de Psychiatrie et Addictologie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Choucha W; INSERM UMR-1178, CESP, Le Kremlin-Bicêtre, France.
  • Gressier F; Department of Epidemiology and Population Health, American University of Beirut, Beirut, Liban.
  • Costemale-Lacoste JF; Faculté de Médecine Paris-Sud, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • de Larminat D; Service de Génétique moléculaire, Pharmacogénétique et Hormonologie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Deflesselle E; Institut National de la Santé et de la Recherche Médicale UMR-S1185, Le Kremlin-Bicêtre, France.
  • Fève B; Faculté de Médecine Paris-Sud, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • Chanson P; INSERM UMR-1178, CESP, Le Kremlin-Bicêtre, France.
  • Becquemont L; Service Hospitalo-Universitaire de Psychiatrie et Addictologie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Verstuyft C; Faculté de Médecine Paris-Sud, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • Corruble E; INSERM UMR-1178, CESP, Le Kremlin-Bicêtre, France.
Aust N Z J Psychiatry ; 54(4): 402-408, 2020 04.
Article em En | MEDLINE | ID: mdl-31823655
ABSTRACT

OBJECTIVE:

Vascular endothelial growth factor A is a growth factor with pro-angiogenic and neurotrophic properties. Anti-vascular endothelial growth factor A treatments, used to treat cancers and opthalmic diseases, are known to induce depressive symptoms. Thus, we hypothesized that vascular endothelial growth factor A plasma levels are low in patients experiencing a major depressive episode in the context of major depressive disorder, which consequently increase after antidepressant treatment. The aim of this study was to compare plasma vascular endothelial growth factor A levels in patients with major depressive episode-major depressive disorder before and after antidepressant treatment.

METHODS:

Vascular endothelial growth factor A fasting plasma levels of 469 major depressive episode-major depressive disorder patients were compared with healthy controls. Depressed patients were assessed for remission after 3 and 6 months of antidepressant treatment. Bivariate and multivariate analyses adjusted for sex, age, body mass index and tobacco use were performed.

RESULTS:

As compared to healthy controls, major depressive episode patients had lower vascular endothelial growth factor A, 66.0 (38.3) pg/mL (standard deviation) vs 83.2 (49.2) pg/mL, p < 0.0001. Plasma vascular endothelial growth factor A levels did not change after antidepressant treatment, even in remitters, and remained lower than those of healthy controls, 64.9 (39.3) pg/mL vs 83.2 (49.2) pg/mL, p < 0.0001.

CONCLUSION:

Depressed patients with major depressive disorder have lower plasma vascular endothelial growth factor A levels than healthy controls during their major depressive episode and after remission following antidepressant treatment. New strategies targeting enhancement of plasma vascular endothelial growth factor A could be promising for the prevention and treatment of major depressive disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article